Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. (Q35039508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

3

Sacha Gnjatic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

6

Danila Valmori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

15

Lloyd J Old

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

9

Gerd Ritter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

16

Alexander Knuth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

Elke Jäger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

2

Julia Karbach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

10

Dirk Jäger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

8

Erika Ritter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

13

Linda Pan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

5

Armin Bender

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

14

Herbert Oettgen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Antje Neumann

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dennis Panicali

series ordinal

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Eric Hoffman

series ordinal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

19 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

number of pages

6

1 reference

Proceedings of the National Academy of Sciences of the United States of America

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

14453-14458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

RECIST revisited: a review of validation studies on tumour assessment

30 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Cancer immunotherapy: moving beyond current vaccines

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

The immunobiology of cancer immunosurveillance and immunoediting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0606512103

Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0606512103

Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcino

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0606512103

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1570182

[New guidelines to evaluate the response to treatment in solid tumors]

25 October 2018

1 reference

12 December 2020

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events

1 reference

12 December 2020

Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer

1 reference

12 December 2020

Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1

1 reference

12 December 2020

Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0606512103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16984998%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

16984998

1 reference